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Background and PurposezzThe risk of suicide or suicide attempts is reported higher in peo-
ple with epilepsy (PWE) than in the general population. Although epileptic, psychiatric, and psy-
chosocial factors are known risk factors for suicide or suicide attempt, no studies have evaluated 
the predictors of the severity of suicidal ideation-which is a warning sign for suicide attempts-in 
PWE. Therefore, we measured the severity of suicidal ideation and its risk factors.
MethodszzConsecutive PWE who were medicated with antiepileptic drugs (AEDs) and attended 
epilepsy clinic were included in the study. The subjects completed self-reported questionnaires, 
which included the Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), Symptom 
Checklist-90-Revised (SCL-90-R), and Scale for Suicide Ideation-Beck (SSI-Beck). We com-
pared the patients’ demographic and clinical variables, and BDI, BAI, and SCL-90-R scores 
with their SSI-Beck score, and used our findings to determine the predictors for suicidal ide-
ation.
ResultszzIn total, 257 PWE were enrolled in the study. SSI-Beck scores correlated strongly with 
several seizure-related variables, duration of education, IQ, BDI and BAI scores, and nine domains 
of the SCL-90-R questionnaire. However, the strongest predictor for suicidal ideation was BDI 
score (β=0.41, p<0.001), followed by several SCL-90-R domains, such as obsessive-compulsive 
(β=-0.39, p<0.001), depression (β=0.38, p<0.001), hostility (β=0.22, p=0.002), paranoid ideation 
(β=0.17, p=0.01), and IQ (β=-0.10, p=0.017). These variables explained 59% of the variance in 
the SSI-Beck score. The seizure-related variables that influenced the BDI score were seizure fre-
quency, duration of education, MRI abnormality, and number of AEDs. However, these variables 
explained only 18% of the variance in the BDI score.
ConclusionszzMajor risk factors for suicidal ideation in PWE were depressive and psychiatric 
symptoms rather than seizure-related variables. Therefore, clinicians should focus on screening for 
depression and other psychiatric problems and treat them appropriately in order to reduce suicidal 
behavior in PWE. Since seizure-related variables also exhibited a minor role in determining de-
pressive symptoms, stronger seizure-related risk factors for depression should be sought, such as 
seizure severity or psychosocial factors, to minimize suicidal behavior.
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Introduction
The suicide rate in Korea in 2008 was reported to be 26.1 per 
100,000 persons by the World Health Organization, which at 
the time was the highest among the Asian countries.
1 People 
who commit suicide in Korea have various medical or psychi-
atric diseases.
2 The most common comorbidity is depression 
(49%), followed by medical or surgical diseases (26%), schi-
zophrenia (10%), dementia (6%), bipolar disorders (4%), men-
tal retardation (3%), neurosis (1%), and alcoholism (1%). Al-
though no data are available in Korea, the risk of suicide or sui-
cide attempt is reportedly higher in people with epilepsy (PWE) 
than in the general population. Two large meta-analyses of 29 
studies comprising 50,814 PWE concluded that suicide is more Predictors of Suicidal Ideation in Epilepsy
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frequent in PWE than in the general population.
3 A popula-
tion-based, case-control study found that the risk of suicide 
was three times higher in PWE than in people with no such 
history.
4 A questionnaire study from Canada found that the 
lifetime prevalence of suicidal ideation was higher in PWE 
(25%) than in people without epilepsy (13%).
5
Various psychiatric comorbidities, including depression and 
anxiety, are known to be primary risk factors for suicide in 
both the general population and PWE.
4,6-8 However, additional 
risk factors should be considered in PWE due to the impact of 
seizure-related factors on suicide. The degree of suicidality 
associated with simple partial seizures, primary generalized sei-
zures, and secondary generalized seizures was found to be hi-
gher than that of complex partial seizures, and temporal lobe 
epilepsy in males represents a risk factor for suicidal behavior.
9 
Furthermore, a high frequency of seizures, independent of sei-
zure type, is a risk factor for suicide,
7 and concomitant use of 
phenobarbital increases the degree of suicidality in females.
9 
Cognitive deterioration and abnormal personality traits due to 
frequent seizures have been reported to increase the risk of sui-
cide.
10 Early age of epilepsy onset, high seizure frequency, and 
antiepileptic drug (AED) polytherapy are also risk factors for 
suicide.
7 In addition to the seizure-related factors, the psycho-
social factors for suicide including family issues, life stress, phy-
sical health, previous suicide attempt, and access to firearms 
should also be considered as risk factors for suicide.
6,11 Fur-
thermore, it is very important to know which factor most in-
fluences suicidal behavior. For example, if this was a seizure-
related factor, we should treat epilepsy itself in order to prevent 
suicide. Conversely, if this was a psychiatric factor, we should 
focus on managing a patient’s psychiatric problems rather than 
treating his or her epilepsy or psychosocial problems.
Predicting suicide is very difficult. Suicidal ideation is a com-
mon medical term for thoughts about suicide, which may be 
as detailed as a formulated plan but without the suicidal act it-
self. Suicidal ideation appears to be an important marker for 
identifying patients at risk of suicide
12 and suicide attempts.
13 
Although most people who experience suicidal ideation do not 
commit suicide, it may be a significant warning sign for suicide 
attempts, especially in high-risk populations such as PWE.
6 
Therefore, the identification of risk factors for suicidal ideation 
may be critical for preventing PWE from committing or at-
tempting suicide.
Once the suicidal risk has been assessed, it is important to 
determine the severity of that risk. According to Jacobs et al.
14 
at this stage it is important to conduct a “suicide inquiry” that 
includes direct questions about suicide ideation, presence or 
absence of a plan, and prior attempts. It is important to assess 
the types of thought that are occurring (e.g., active or passive), 
the frequency and persistence of those thoughts, and the fac-
tors that stop the person from following through with the sui-
cide.
14,15 Although there are simple methods that can be used 
to screen for suicidal ideation, such as the suicidality module 
of the Mini-International Neuropsychiatric Interview
16 and the 
suicide item (question 9) of the Beck Depression Inventory 
(BDI),
17 their simplicity (i.e., all or nothing assessment) makes 
them unsuitable for measure the severity of suicidal ideation. 
On the other hand, the Scale for Suicide Ideation-Beck (SSI-
Beck) is a useful 19-item, self-reported questionnaire designed 
to detect and measure the severity of a patient’s specific atti-
tudes, behaviors, and plans to commit suicide.
18 Although epi-
leptic, psychiatric, and psychosocial factors have been related 
to suicide or suicide attempt in PWE, no studies have evalu-
ated predictors for the severity of suicidal ideation-a warning 
sign for suicide attempt-in PWE. Therefore, we measured the 
severity of suicidal ideation in PWE and determined its risk 
factors. We also investigated the role of seizure-related vari-
ables in suicidal ideation, since some of those variables are 
treatable, and can thereby lessen the risk of suicidal behavior.
Methods
Subjects and study design
The study included 257 consecutive PWE who were medicat-
ed with AEDs and attended our epilepsy clinic between April 1, 
2007 and October 31, 2009. We excluded patients who had un-
dergone epilepsy surgery, and who had severe psychiatric or 
medical disorders, progressive neurological disorders, head in-
jury, mental retardation (Korean-Wechsler Adult Intelligence 
Scale IQ <70),
19 or alcohol or drug abuse. At enrollment, all sub-
jects completed reliable and validated self-reported health ques-
tionnaires, including the BDI,
20 Beck Anxiety Inventory (BAI),
21 
Symptom Checklist-90-Revised (SCL-90-R),
22 and SSI-Beck.
23 
The subjects provided informed consent to participate in the 
study prior to completing the questionnaires. Demographic and 
clinical data were collected by interview and from information 
given in the patient’s epilepsy diary. Seizure-related factors, 
such as seizure type, epilepsy syndrome, age at onset, duration 
of epilepsy, seizure frequency, duration of AED intake, num-
ber of AEDs, history of febrile convulsion, family history of 
epilepsy, and abnormalities on MRI and EEG were included.
We divided the PWE into the following three groups to de-
termine the seizure frequency:
1) Drug-refractory epilepsy (DRE): defined as a failure of 
two or more AEDs and a seizure frequency of at least once per 
month for the previous 6 months before enrollment.
2) Well-controlled epilepsy (WCE): defined as a freedom 
from seizures for the previous year.
3) Poorly controlled epilepsy (PCE): defined as a seizure re-
currence during the previous year, but not satisfying the cri- Lim HW et al.
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teria of DRE.
We also divided PWE into two groups according to the use 
or nonuse of γ-aminobutyric acid (GABA)-ergic AEDs. Since 
GABAergic AEDs are known to elicit depressive symptoms,
24 
we compared SSI-Beck scores between patients receiving GA-
BAergic drugs and those not receiving GABAergic drugs. Val-
proate, topiramate, phenobarbital, clonazepam, vigabatrin, and 
gabapentin are classified as GABAergic AEDs according to 
the literature of Ketter et al.
25 We compared demographic and 
clinical variables, and BDI, BAI, and SCL-90-R scores with 
the SSI-Beck scores, and used the findings to determine the risk 
factors for suicidal ideation. We also investigated the impact of 
seizure-related variables on those risk factors.
Questionnaires
BDI	and	BAI
The BDI is the most commonly used self-rating scale for de-
pression.
20 It comprises 21 items, each of which is scored on a 
scale of 0-3 according to how the patient feels at the current 
time. The BDI has been found to be strongly correlated with 
other ratings of depression, such as the Hamilton Depression 
Scale used by psychiatrists to rate depression. The BAI is a 
21 item self-reported measure of anxiety severity.
21 The scale 
consists of 21 items, each describing a common symptom of an-
xiety. The respondent is asked to rate how much he or she has 
been bothered by each symptom during the previous week, also 
on a 4-point scale ranging from 0 to 3. The Cronbach’s alpha 
coefficients were 0.89 for BDI and 0.91 for BAI.
SCL-90-R
The SCL-90-R is a self-rated scale that has 9 psychiatric symp-
tom domains, comprising 90 items with a rating scale with 5 
degrees of severity.
22 The psychiatric domains evaluated are so-
matization (alpha=0.72), obsessive-compulsive (alpha=0.83), 
interpersonal sensitivity (alpha=0.84), depression (alpha= 
0.89), anxiety (alpha=0.86), hostility (alpha=0.68), phobic an-
xiety (alpha=0.81), paranoid ideation (alpha=0.69), and psy-
choticism (alpha=0.67). The SCL-90-R index and symptom-
scale scores are represented as T-scores, with a mean of 50 and 
a standard deviation of 10. Higher T-scores reflect a greater num-
ber and/or severity of a patient’s self-reported symptoms.
SSI-Beck
The SSI-Beck is a 19-item, self-reported measure designed to 
evaluate the current severity of a patient’s specific attitudes, be-
haviors, and plans to commit suicide.
18,23 The items are rated 
on a 3-point scale from 0 to 2. The total score can range from 
0 to 38, with higher scores indicating more intense levels of sui-
cidal ideation. Cronbach’s alpha coefficients were 0.87 for sub-
jects of the study of Korean version of SSI-Beck
23 and 0.82 
for those of our study.
Statistical analysis
Data were analyzed using the Statistical Package for the So-
cial Sciences (SPSS version 17.0, SPSS Inc, Chicago, IL, USA). 
Descriptive statistics are presented in terms of counts, percent-
ages, and mean±standard deviation values. The Mann-Whit-
ney U-test or Kruskal-Wallis test for independent samples was 
applied to elucidate the differences in SSI-Beck scores accord-
ing to seizure type, EEG and MRI abnormalities, psychiatric 
history, seizure frequency, and number of AEDs. We used sim-
ple linear correlations to evaluate the relationship between SSI-
Table 1. Demographic and clinical characteristics of the people 
with epilepsy who were enrolled in this study
Characteristic
Patients
(n=257)
Age, years, mean (SD) 035.1 (12.5)
Males (%)  060
Duration of education, years, mean (SD) 012.8 (3.0)
IQ  103.3 (15.5)
Seizure type, no. (%)
Partial 0.181 (70)
Generalized 0.076 (30)
Etiology, no. (%)
Idiopathic or cryptogenic 0.169 (66)
Symptomatic 00.88 (34)
Syndrome, no. (%)
Temporal lobe epilepsy 0.105 (40)
Other localized epilepsy 00.76 (30)
Generalized epilepsy 00.76 (30)
Age at epilepsy onset, years, mean (SD) 023.9 (13.4)
Duration of epilepsy, years, mean (SD) 011.2 (9.3)
Seizure frequency, no. (%)
Well-controlled epilepsy* 00132 (51)
Poorly controlled epilepsy† 00.54 (21)
Drug-refractory epilepsy‡ 00.71 (28)
Concomitant medical diseases, no. (%) 00.39 (15)
Previous history of psychiatric diseases, no. (%) 00.38 (15)
Previous history of febrile convulsions, no. (%) 00.47 (18)
Family history of epilepsy, no. (%) 00.23 (9)
MRI abnormality, no. (%) 00.72 (28)
EEG abnormality, no. (%) 00.71 (28)
Duration of AEDs intake, years, mean (SD) 008.5 (8.3)
Number of AEDs, mean (SD) 001.4 (0.6)
Intake of GABAergic AEDs, no. (%) 00.82 (32)
*Freedom from seizures during the previous year, †Seizure recur-
rence during the previous year, but not satisfying the criteria of 
drug refractory epilepsy, 
‡Failure of two or more antiepileptic 
drugs (AEDs) and a seizure frequency of at least once per mon-
th during the previous 6 months.
GABAergic: γ-aminobutyric acid-ergic.Predictors of Suicidal Ideation in Epilepsy
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Beck scores and duration of education, IQ, and BDI, BAI, and 
SCL-90-R scores. Finally, a stepwise multiple linear regression 
analysis was used to study the multivariate relationships be-
tween covariables and SSI-Beck and BDI scores. Dummy cod-
ing was used for independent variables. Epilepsy syndrome, 
seizure frequency, and number of AEDs were categorized as 
three groups. The level of statistical significance was set at 
p<0.05.
Results
The demographic and clinical characteristics of the 257 PWE 
enrolled in this study (age 35.1±12.5 years, 60% males) are 
listed in Table 1. The duration of education was 12.8±3.0 years, 
and the IQ of the cohort was 103.3±15.5.
Regarding seizure type, 181 patients (70%) suffered from 
partial seizure and 76 patients (30%) from generalized seizure. 
The most common epilepsy syndrome was temporal lobe ep-
ilepsy. The age at onset and duration of epilepsy were 23.9± 
13.4 years and 11.2±9.3 years, respectively. Regarding seizure 
frequency, the proportions of WCE, PCE, and DRE were 51%, 
21%, and 28%, respectively. Concomitant medical diseases 
were found in 15% of patients. The incidences of previous his-
tory of psychiatric diseases and febrile convulsion were 15% 
and 18%, respectively. The prevalence of a family history of 
epilepsy was low. The proportions of abnormal MRI and EEG 
findings were similar. The duration of AED intake was 8.5± 
8.3 years, and the number of AEDs being used per patient was 
1.4±0.6; 32% of patients took AEDs with a GABAergic profile.
The scores of the entire cohort (i.e., n=257) for the various 
psychometric tests are listed in Table 2, and a comparison of 
the categorized variables among the demographic and clinical 
characteristics with the SSI-Beck score is given in Table 3. The 
SSI-Beck score was significantly correlated with sex (p=0.041), 
seizure frequency (p<0.001), previous history of psychiatric 
diseases (p<0.001), MRI abnormality (p=0.016), and EEG ab-
normality (p=0.005). The continuous variables are compared 
with the SSI-Beck score in Table 4. The duration of education 
Table 2. Affective and psychiatric symptoms and suicidal ideation
Battery
Patients (n=257)
mean (SD)
BDI score 13.0 (10.9)
BAI score 11.2 (11.4)
SCL-90-R scores
Somatization 48.6 (10.1)
Obsessive-compulsive 48.1 (11.4)
Interpersonal sensitivity 48.5 (12.0)
Depression 47.5 (11.5)
Anxiety 48.1 (11.2)
Hostility 48.6 (10.9)
Phobic anxiety 51.7 (13.5)
Paranoid ideation 47.1 (11.4)
Psychoticism 48.8 (11.3)
SSI-Beck score 4.7 (6.4)
BDI: Beck Depression Inventory, BAI: Beck Anxiety Inventory, SCL-
90-R: Symptom Checklist-90-Revised (T-scores), SSI-Beck: Scale 
for Suicide Ideation-Beck.
Table 3. Univariate analyses comparing categorized variables with 
SSI-Beck score
Variable  Z or χ2 p*
Sex -2.04 0.041
Seizure type -1.49 0.135
Etiology -0.68 0.498
Syndrome 4.17 0.125
Seizure frequency 19.93 <0.001
Concomitant medical diseases -0.83 0.408
Previous history of psychiatric diseases -4.97 <0.001
Previous history of febrile convulsions -0.42 0.674
Family history of epilepsy -0.62 0.535
MRI abnormality -2.42 0.016
EEG abnormality -2.82 0.005
Number of AEDs 4.97 0.083
Intake of GABAergic AEDs -0.62 0.534
*Mann-Whitney U-test or Kruskal-Wallis test for independent sam-
ples was applied.
GABAergic: γ-aminobutyric acid-ergic, AEDs: antiepileptic drugs.
Table 4. Univariate analyses comparing continuous variables with 
SSI-Beck score
Variable r p*
Age 0.02 0.755
Duration of education -0.13 0.032
IQ -0.24 <0.001
Age at epilepsy onset -0.02 0.698
Duration of epilepsy 0.06 0.328
Duration of AED intake <0.01 0.982
BDI score 0.70 <0.001
BAI score 0.57 <0.001
SCL-90-R scores
Somatization 0.49 <0.001
Obsessive-compulsive 0.56 <0.001
Interpersonal sensitivity 0.62 <0.001
Depression 0.68 <0.001
Anxiety 0.61 <0.001
Hostility 0.64 <0.001
Phobic anxiety 0.51 <0.001
Paranoid ideation 0.57 <0.001
Psychoticism 0.63 <0.001
*Simple linear correlation was applied.
BDI: Beck Depression Inventory, BAI: Beck Anxiety Inventory, SCL-
90-R: Symptom Checklist-90-Revised (T-scores), AED: antiepi-
leptic drug. Lim HW et al.
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(r=-0.13, p=0.032), IQ (r=-0.24, p<0.001), BDI score (r=0.7, 
p<0.001), BAI score (r=0.57, p<0.001), and nine domains of 
SCL-90-R [i.e., somatization (r=0.49, p<0.001), obsessive-
compulsive (r=0.56, p<0.001), interpersonal sensitivity (r= 
0.62, p<0.001), depression (r=0.68, p<0.001), anxiety (r= 
0.61, p<0.001), hostility (r=0.64, p<0.001), phobic anxiety 
(r=0.51, p<0.001), paranoid ideation (r=0.57, p<0.001), and 
psychoticism (r=0.63, p<0.001)] were significantly correlat-
ed with SSI-Beck score.
The predictors of suicidal ideation as revealed by a step-
wise multiple linear regression analysis of our findings are 
listed in Table 5. The strongest predictor of the SSI-Beck score 
was the BDI score (β=0.41, p<0.001), followed by several do-
mains of SCL-90-R, such as obsessive-compulsive (β=-0.39, 
p<0.001), depression (β=0.38, p<0.001), hostility (β=0.22, p= 
0.002), paranoid ideation (β=0.17, p=0.01), and IQ (β=-0.10, 
p=0.017). These variables explained 59% of the variance in 
the SSI-Beck score.
Seizure-related variables determining the BDI score revealed 
by a stepwise multiple linear regression analysis are listed in 
Table 6. The strongest predictor of the BDI score was seizure 
frequency (β=0.21, p=0.004), followed by duration of educa-
tion (β=-0.17, p=0.003), MRI abnormality (β=0.17, p=0.004), 
and number of AEDs (β=0.14, p=0.042). These variables ex-
plained only 18% of the variance in the BDI score.
Discussion
Suicide appears to be a particularly serious among people 
with chronic epilepsy who require treatment in specialty clin-
ics.
26 A case-control study of adults who had been hospitalized 
with epilepsy found a ninefold increase in risk of suicide with 
psychiatric comorbidity and a tenfold increase in relative risk 
with the use of antipsychotic drugs.
7 In a cross-sectional study 
among 139 outpatients followed in 5 tertiary epilepsy centers 
in the United States, the highest risks for a suicide attempt 
Table 5. Variables determining the SSI-Beck score using stepwise multiple linear regression analysis
Model
Unstandardized coefficient Standardized 
coefficient β
R2 Adjusted R2
B SE
1 (Constant) -0.63 0.45 0.49 0.48
BDI score 0.41 0.03 -0.7†
2 (Constant) -7.56 1.43 0.53 0.53
BDI score 0.29 0.03 -0.5
†
Hostility 0.18 0.03 -0.3
†
3 (Constant) -3.13 2.43 0.54 0.54
BDI score 0.28 0.03 -0.48
†
Hostility 0.18 0.03 -0.3
†
IQ -0.04 0.02 -0.1*
4 (Constant) -4.87 2.51 0.55 0.55
BDI score 0.22 0.04 -0.37
†
Hostility 0.12 0.04 -0.21
†
IQ -0.05 0.02 -0.11*
Depression 0.11 0.05 -0.2*
5 (Constant) -4.26 2.45 0.58 0.57
BDI score 0.23 0.04 -0.39
†
Hostility 0.16 0.04 -0.28
†
IQ -0.04 0.02 -0.1*
Depression 0.23 0.06 -0.42
†
Obsessive-compulsive -0.18 0.05 -0.33
†
6 (Constant) -4.38 2.43 0.59 0.58
BDI score 0.24 0.04 -0.41
†
Hostility 0.13 0.04 -0.22
†
IQ -0.04 0.02 -0.1*
Depression 0.21 0.06 -0.38
†
Obsessive-compulsive -0.22 0.05 -0.39
†
Paranoid ideation 0.10 0.04 -0.17*
*p<0.05, 
†p<0.01.
SSI-Beck: Scale for Suicide Ideation-Beck, BDI: Beck Depression Inventory.Predictors of Suicidal Ideation in Epilepsy
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were associated with lifetime histories of major depressive ep-
isodes and manic episodes; a lifetime history of a mood and/or 
anxiety disorder was found to be significantly associated with 
the risk of suicidal ideation.
6 A population-based study of sui-
cide victims over a 15-year period in northern Finland sug-
gested that suicide victims with epilepsy had suffered signifi-
cantly more often from psychiatric disorders in their lifetime 
compared with those without epilepsy.
8 A large, case-control 
study in Denmark, using five nationwide registries to obtain 
information about epilepsy, cause of death, psychiatric diagno-
ses, socioeconomic data, and demographic data, demonstrated 
that psychiatric history was a strong risk factor for suicide, even 
after adjusting for socioeconomic factors, and that affective 
disorder was the most common psychiatric disorder associat-
ed with the risk of suicide.
4 Although we did not evaluate the 
predictors of suicide or suicide attempt, we found that the se-
verity of suicidal ideation was also strongly correlated with BDI 
scores and other psychiatric symptoms.
Seizure-related variables including seizure type, epilepsy 
syndrome, seizure frequency, onset of epilepsy, and AED poly-
therapy have been reported to predict suicidality in PWE.
7,9 
However, there is a lack of available data on the psychiatric 
impact on seizure-related variables
9 and only a weak associa-
tion between seizure frequency or AED polytherapy and sui-
cidality has been reported,
7 and thus it has not been possible 
to explain the role of seizure-related variables on suicidal be-
havior. Our data also revealed that seizure-related variables are 
not major risk factors for suicide as well as depressive symp-
toms in PWE. Although the individual influence of seizure-re-
lated variables on suicidality is small, we should consider that 
these variables might together contribute to eliciting suicidal 
ideation. Seizure severity, as measured by assessing seizure 
frequency, type, duration, postictal events and duration, the oc-
currence of injuries, automatism, seizure clusters, warnings, ton-
gue biting, incontinence, and overall functional impairment, 
was strongly correlated with the level of depression.
27 There-
fore, further studies are needed to evaluate the effects of seizure 
severity on suicidal behavior.
It has been suggested that AEDs are involved in the increased 
risk of suicidal behavior in PWE. GABAergic drugs including 
vigabatrin, tiagabine, topiramate, and phenobarbital can report-
edly provoke or exacerbate depressive symptoms.
24 The risk of 
developing major depressive disorders and suicidal ideation is 
higher in children taking phenobarbital than in those taking car-
bamazepine.
28 However, we were unable to demonstrate a harm-
ful effect of GABAergic AEDs on suicidal ideation. This can 
be explained by the involvement of valproate, a known mood-
stabilizing agent,
24,25 as a GABAergic AED. In our study val-
proate was used by as many as 42% of our patients, which may 
have attenuated the overall effect of GABAergic AEDs on 
mood or suicidal ideation. Although we did not demonstrate a 
harmful effect of AEDs on suicidality, the United States Food 
and Drug Administration (FDA) recently issued a warning re-
garding AEDs and suicidality.
29 A meta-analysis of data from 
placebo-controlled trials with 11 different AEDs demonstrated 
that the odds ratio for suicidal ideation or behavior in the drug 
arms was 1.8 (95% CI, 1.24-2.66). Although the FDA alert 
raises potential problems regarding study interpretation due 
to methodological difficulties and the lack of information re-
garding the state of seizure control,
30 we should routinely eval-
uate depression and suicidality in PWE until future clinical 
trials with validated instruments determine whether the possi-
Table 6. Seizure-related variables determining the BDI score, revealed using stepwise multiple linear regression analysis
Model
Unstandardized coefficient Standardized 
coefficient β
R2 Adjusted R2
B SE
1 (Constant) 9.81 0.86 0.11 0.11
Seizure frequency 4.24 0.75 -0.33†
2 (Constant) 8.81 0.90 0.15 0.14
Seizure frequency 3.91 0.75 -0.31
†
MRI abnormality 4.47 1.42 -0.18
†
3 (Constant) 16.62 2.94 0.17 0.16
Seizure frequency 3.67 0.74 -0.29
†
MRI abnormality 4.35 1.40 -0.18
†
Duration of education -0.59 0.21 -0.16
†
4 (Constant) 14.49 3.10 0.18 0.17
Seizure frequency 2.62 0.90 -0.21
†
MRI abnormality 4.12 1.40 -0.17
†
Duration of education -0.64 0.21 -0.17
†
Number of AEDs 2.62 1.28 -0.14*
*p<0.05, 
†p<0.01.
BDI: Beck Depression Inventory. Lim HW et al.
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ble signal observed by the FDA is real.
Sex and age appear to be important factors in predicting 
suicide. According to a report of the Korean Institute of Crimi-
nology, the rate of suicide in Korea is 2.3-fold higher among 
males than among females, and was highest in the elderly.
2 
However, we could not substantiate these findings in our PWE 
cohort; moreover, these factors were not found to be predic-
tors of suicide.
Neurologists are not expected to manage the psychiatric dis-
orders of PWE with suicidal ideation or behavior; however, it 
should be possible to identify the risks of suicidality from kn-
owledge of the patient’s current or past history of mood dis-
order, family history of mood or suicidal behavior, and previ-
ous suicide attempts.
31 Self-report instruments aimed at iden-
tifying major depressive episodes, such as the BDI
17 and the 
Hospital Anxiety and Depression Scale,
32 can be implement-
ed to measure the severity of depressive symptoms. Recently, 
a simple, six-item self-rating screening instrument, the Neuro-
logical Disorders Depression Inventory for Epilepsy, which 
takes less than 3 minutes to complete, was developed to iden-
tify major depressive episodes specifically for PWE.
33 A score 
on this scale of ≥15 is suggestive of a major depressive epi-
sode and should be lead to referral to a psychiatrist for further 
evaluation.
The limitation of our study was that we did not consider psy-
chosocial issues as risk factors for suicide. Among various psy-
chosocial factors, such as family issues, life stress, physical he-
alth, previous suicide attempt, and access to firearms,
6,11 a his-
tory of suicide attempt is the strongest predictor for a successful 
suicide attempt. For example, PWE who attempted suicide 
had a 38-fold increased risk of a subsequent successful sui-
cide compared with the general population.
34 Likewise, in a 
Swedish population-based study, a previous suicide attempt 
was identified in 46% of PWE who eventually committed sui-
cide.
7 As a major determinant of suicidality, depression also 
seems to be correlated with a lack of occupational and social 
activity, or an unmarried state.
35,36 Therefore, further studies 
should be conducted to establish the impact of psychosocial 
factors on suicide or depression.
Despite its limitations, to our knowledge this is the first 
study to clarify the risk factors for suicidality in PWE living 
in Korea. We established that major risk factors for suicidal 
ideation in PWE were depressive and psychiatric symptoms, 
rather than seizure-related variables. Therefore, clinicians 
should focus on screening for depression and other psychiatric 
problems and treat them appropriately to prevent PWE from 
developing suicidal behaviors. Since seizure-related variables 
also play a minor role in determining depressive symptoms, 
we should seek stronger risk factors for depression, such as 
seizure severity or psychosocial factors, to minimize the sui-
cidal behavior.
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